These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29785657)

  • 1. Novel non-invasive early detection of lung cancer using liquid immunobiopsy metabolic activity profiles.
    Adir Y; Tirman S; Abramovitch S; Botbol C; Lutaty A; Scheinmann T; Davidovits E; Arbel I; Davidovits G; Schneer S; Shteinberg M; Peretz Soroka H; Tirosh R; Patolsky F
    Cancer Immunol Immunother; 2018 Jul; 67(7):1135-1146. PubMed ID: 29785657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomic-based biomarker discovery for non-invasive lung cancer screening: A case study.
    O'Shea K; Cameron SJ; Lewis KE; Lu C; Mur LA
    Biochim Biophys Acta; 2016 Nov; 1860(11 Pt B):2682-7. PubMed ID: 27423423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary metabolomic biomarkers for non-invasive lung cancer detection.
    Kajiwara N; Kakihana M; Maeda J; Kaneko M; Ota S; Enomoto A; Ikeda N; Sugimoto M
    Cancer Sci; 2024 May; 115(5):1695-1705. PubMed ID: 38417449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum lipidomic biomarkers for non-small cell lung cancer in nonsmoking female patients.
    Noreldeen HAA; Du L; Li W; Liu X; Wang Y; Xu G
    J Pharm Biomed Anal; 2020 Jun; 185():113220. PubMed ID: 32145537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood test shows high accuracy in detecting stage I non-small cell lung cancer.
    Goebel C; Louden CL; Mckenna R; Onugha O; Wachtel A; Long T
    BMC Cancer; 2020 Feb; 20(1):137. PubMed ID: 32085733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel, accurate, and non-invasive liquid biopsy test to measure cellular immune responses as a tool to diagnose early-stage lung cancer: a clinical trials study.
    Shai S; Patolsky F; Drori H; Scheinman EJ; Davidovits E; Davidovits G; Tirman S; Arber N; Katz A; Adir Y
    Respir Res; 2023 Feb; 24(1):52. PubMed ID: 36788537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolite Profiles of the Serum of Patients with Non-Small Cell Carcinoma.
    Mazzone PJ; Wang XF; Beukemann M; Zhang Q; Seeley M; Mohney R; Holt T; Pappan KL
    J Thorac Oncol; 2016 Jan; 11(1):72-8. PubMed ID: 26762741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomic investigation of urinary extracellular vesicles for early detection and screening of lung cancer.
    Yang Q; Luo J; Xu H; Huang L; Zhu X; Li H; Yang R; Peng B; Sun D; Zhu Q; Liu F
    J Nanobiotechnology; 2023 May; 21(1):153. PubMed ID: 37189121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive diagnosis of early-stage lung cancer using high-throughput targeted DNA methylation sequencing of circulating tumor DNA (ctDNA).
    Liang W; Zhao Y; Huang W; Gao Y; Xu W; Tao J; Yang M; Li L; Ping W; Shen H; Fu X; Chen Z; Laird PW; Cai X; Fan JB; He J
    Theranostics; 2019; 9(7):2056-2070. PubMed ID: 31037156
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolomic Fingerprinting for the Detection of Early-Stage Lung Cancer: From the Genome to the Metabolome.
    Haince JF; Joubert P; Bach H; Ahmed Bux R; Tappia PS; Ramjiawan B
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening.
    Sestini S; Boeri M; Marchiano A; Pelosi G; Galeone C; Verri C; Suatoni P; Sverzellati N; La Vecchia C; Sozzi G; Pastorino U
    Oncotarget; 2015 Oct; 6(32):32868-77. PubMed ID: 26451608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-resolution metabolomic biomarkers for lung cancer diagnosis and prognosis.
    Qi SA; Wu Q; Chen Z; Zhang W; Zhou Y; Mao K; Li J; Li Y; Chen J; Huang Y; Huang Y
    Sci Rep; 2021 Jun; 11(1):11805. PubMed ID: 34083687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation profiles of bronchoscopic biopsies for the diagnosis of lung cancer.
    Goldmann T; Schmitt B; Müller J; Kröger M; Scheufele S; Marwitz S; Nitschkowski D; Schneider MA; Meister M; Muley T; Thomas M; Kugler C; Rabe KF; Siebert R; Reck M; Ammerpohl O
    Clin Epigenetics; 2021 Feb; 13(1):38. PubMed ID: 33596996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CTAPIII/CXCL7: a novel biomarker for early diagnosis of lung cancer.
    Du Q; Li E; Liu Y; Xie W; Huang C; Song J; Zhang W; Zheng Y; Wang H; Wang Q
    Cancer Med; 2018 Feb; 7(2):325-335. PubMed ID: 29356357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and Validation of a Lung Cancer Diagnostic Model Based on 6-Gene Methylation Frequency in Blood, Clinical Features, and Serum Tumor Markers.
    Kang C; Wang D; Zhang X; Wang L; Wang F; Chen J
    Comput Math Methods Med; 2021; 2021():9987067. PubMed ID: 34257703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening and staging for non-small cell lung cancer by serum laser Raman spectroscopy.
    Wang H; Zhang S; Wan L; Sun H; Tan J; Su Q
    Spectrochim Acta A Mol Biomol Spectrosc; 2018 Aug; 201():34-38. PubMed ID: 29729529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Epigenetic Signature for Early Diagnosis in Lung Cancer.
    Diaz-Lagares A; Mendez-Gonzalez J; Hervas D; Saigi M; Pajares MJ; Garcia D; Crujerias AB; Pio R; Montuenga LM; Zulueta J; Nadal E; Rosell A; Esteller M; Sandoval J
    Clin Cancer Res; 2016 Jul; 22(13):3361-71. PubMed ID: 26842235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancer.
    Ostroff RM; Bigbee WL; Franklin W; Gold L; Mehan M; Miller YE; Pass HI; Rom WN; Siegfried JM; Stewart A; Walker JJ; Weissfeld JL; Williams S; Zichi D; Brody EN
    PLoS One; 2010 Dec; 5(12):e15003. PubMed ID: 21170350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential miRNA expressions in peripheral blood mononuclear cells for diagnosis of lung cancer.
    Ma J; Lin Y; Zhan M; Mann DL; Stass SA; Jiang F
    Lab Invest; 2015 Oct; 95(10):1197-206. PubMed ID: 26146958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolomic markers of altered nucleotide metabolism in early stage adenocarcinoma.
    Wikoff WR; Grapov D; Fahrmann JF; DeFelice B; Rom WN; Pass HI; Kim K; Nguyen U; Taylor SL; Gandara DR; Kelly K; Fiehn O; Miyamoto S
    Cancer Prev Res (Phila); 2015 May; 8(5):410-8. PubMed ID: 25657018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.